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ABSTRACT  
Thyroid hormones regulate both, hair growth and mitochondrial functions. Since the other 
hypothalamic-pituitary-thyroid (HPT) axis hormones, i.e. thyrotropin-releasing hormone 
(TRH) and thyrotropin (TSH), are expressed in human hair follicles (HFs) and regulate 
mitochondrial functions in human epidermis, we have investigated in organ-cultured human 
scalp HFs whether TRH (30 nM), TSH (10 mU/ml), thyroxine (T4) (100 nM) and 
triiodothyronine (T3) (100 pM) alter intrafollicular mitochondrial biology and energy 
metabolism.  All HPT-axis members increased gene and protein expression of MTCO1, a 
key subunit of complex IV of the electron transport chain, and of TFAM, a key transcription 
factor that controls mitochondrial DNA synthesis. T3, T4, TSH, and TRH also stimulated 
intrafollicular complex I and IV activity and promoted intrafollicular mitochondrial biogenesis. 
Notably, T3 also increased follicular heat production. HPT-axis hormones did not increase 
ROS production in cultured human HF keratinocytes, T3 and T4 even reduced ROS 
formation, and all HPT-axis hormones increased transcription of ROS-scavenging key 
enzymes (catalase and/or SOD2) in these cells. Thus, mitochondrial biology, energy 
metabolism, and redox state of human HFs are subject to profound (neuro-)endocrine 
regulation by HPT-axis hormones. The novel neuroendocrine controls of mitochondrial 
biology in a complex human mini-organ identified here may be therapeutically exploitable. 
 
 
INTRODUCTION  
The hypothalamic-pituitary-thyroid (HPT)-axis controls multiple metabolic processes in 
vertebrate organisms (Bassett et al., 2008; Costa-E-Sousa et al., 2012), including human 
skin (Paus et al., 2010, 2011). Stimulation of the pituitary gland by hypothalamus-derived 
TRH leads to TSH secretion. TSH then stimulates thyroid gland activity, namely synthesis 
and secretion the thyroid hormones (THs), thyroxine (T4) and triiodothyronine (T3) (Zoeller et 
al., 2007). Circulating T4 is thought to largely act after deiodination into T3 in peripheral 
organs, including human hair follicles (HFs) (Kaplan et al., 1988; Safer et al., 2009; van Beek 
et al., 2008).  
Several elements of the HPT-axis are also expressed in human skin in situ and/or some of its 
constituent cell populations in vitro (Slominski et al., 2002; Paus, 2010). For example, TRH 
mRNA has been identified in cultured human dermal and HF fibroblasts (Slominski et al., 
2002), while TSH mRNA and protein is found in normal human epidermis (Bodó et al., 2010), 
and TSH receptor (TSH-R) transcripts and protein in human skin and HF mesenchyme 
(Bodó et al., 2009; Cianfarani et al., 2010). Both TRH and its receptor (TRH-R) are 
expressed in the epithelium of normal human scalp HFs (Gáspár et al., 2010, 2011). Human 
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skin may therefore possess a peripheral equivalent of the central HPT-axis (Slominski et al., 
2002, Bodó et al., 2010; Paus, 2010).  
THs directly alter important human HF functions, e.g. THs prolong anagen, stimulate hair 
matrix keratinocyte proliferation and pigmentation, and modulate intrafollicular keratin 
expression (van Beek et al., 2008). Instead, the intrafollicular functions of TSH, which 
regulates the expression of selected keratins in human HFs (Ramot et al., 2011), remain 
unclear (Bodó et al., 2009; Paus, 2010). However, TRH has surfaced as a potent stimulator 
of human hair growth and pigmentation (Gáspár et al., 2010, 2011) and regulates 
intrafollicular prolactin and prolactin-receptor expression in situ (Langan et al., 2010).  
THs greatly impact on mitochondria (Harper et al., 2008, Weitzel et al., 2003, 2011), whose 
activities control human energy metabolism and homeostasis, (Scheffler, 2008, Portman, 
2008; Kharlip et al., 2009). Mitochondria process products of glycolysis and fatty acid 
oxidation to generate ATP, contain enzymes critical for multiple biosynthetic processes, 
contribute to the amino acid metabolism and ion homeostasis, regulate cell death pathways 
by ROS and Ca2+ signalling, and are involved in aging, cancer development and the 
pathogenesis of an ever-increasing list of human diseases (Larsson, 2010; Birch-Machin, 
2006; Scheffler, 2008; Wallace and Fan, 2009; Wallace, 2010). Therefore, fully 
understanding the hormonal controls of mitochondrial biology is of major biological and 
clinical interest. 
Though mainstream mitochondrial research has largely ignored human skin as a research 
model, human skin actually is a most instructive model system for identifying novel, clinically 
relevant hormonal controls of mitochondrial function and biogenesis. Namely, both TRH and 
TSH are previously unknown, yet powerful neuroendocrine regulators of mitochondrial 
biology in human epidermis (Poeggeler et al., 2010a; Knuever et al., 2012). However, 
whether THs, TRH and/or TSH exert a similar function in human HFs was unknown as HF 
mitochondrial biology has remained almost completely unexplored. Since hair growth is a 
highly energy-consuming process (Kealey et al., 1994; Stenn and Paus, 2001), we 
hypothesized that these HPT-axis hormones may also regulate human HF energy 
metabolism and mitochondrial function.  
Therefore, using serum-free organ culture of healthy human scalp HFs (Philpott et al., 1990; 
Kloepper et al., 2010), we asked whether and how TRH, TSH and THs influence 
intrafollicular mitochondrial biology in the absence of all neural, vascular, and extrafollicular 
hormonal inputs. The list of mitochondrial read-out parameters that we had previously 
established and reported for organ-cultured human epidermis (Poeggeler et al., 2010a; 
Knuever et al., 2012) was further extended, notably including porin expression as an 
additional indicator of mitochondrial biogenesis (Feichtinger et al., 2011) and calorimetry as 
an indicator of mitochondrial energy metabolism-dependent heat production (Lerchner et al., 
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2008a, b). Furthermore, in cultured human ORS (outer root sheath) keratinocytes, 
mitochondrial data were correlated with ROS production and the expression of important 
ROS scavenging enzymes (catalase, SOD2).  
Collectively, these studies provide the first evidence that all examined key players of the 
HPT-axis profoundly stimulate mitochondrial biology and regulate the redox state of human 
HFs. 
 
 
RESULTS 
 
HPT-axis elements increase MTCO1 and TFAM protein expression in situ while T3/T4 
stimulate MTCO1 and TFAM transcription 
Previously, we had shown that TSH upregulates MTCO1 gene and protein expression in 
human HFs (Bodó et al., 2009) and human epidermis, where TSH also increases the 
expression of TFAM (Poeggeler et al., 2010a). TFAM controls mitochondrial DNA synthesis 
(Scarpulla, 2008) by initiating mtDNA replication and mitochondrial protein transcription 
(Maniura-Weber et al., 2004; Viña et al., 2009; Hallberg et al., 2011) and is thus 
indispensable for a functional electron transport chain (Baris et al., 2011). TFAM also 
appears to be important for the maintenance and stabilization of mitochondrial DNA (Larsson 
et al., 1998). Therefore, we assessed the impact of HPT-axis hormones on MTCO1 and 
TFAM expression in human scalp HFs. 
We found that T3, T4 and TSH significantly increase MTCO1-IR in the proximal ORS in situ 
wether TRH only showed a slight increase in IR (Figure 1a-f). Moreover, TH treatment 
increased intrafollicular MTCO1 mRNA transcription (Figure 1g). Furthermore, TFAM protein 
expression in situ was significantly increased after 24 hrs of treatment with TRH, TSH and 
THs (Figure 2a-f), T3 and T4 also stimulated TFAM mRNA expression (Figure 2g). 
 
T3/T4, TRH and TSH treatment increases mitochondrial biogenesis 
These TFAM data raised the question whether these HPT-axis hormones can actually 
stimulate mitochondrial biogenesis in the HF, just as we had already shown for TSH and 
TRH in human epidermis (Poeggeler et al., 2010a; Knuever et al., 2012). TEM showed that 
the number of ultrastructurally detectable mitochondria was upregulated by all HPT-axis 
players, particularly in the perinuclear region of human ORS keratinocytes (Figure 3a-f).  
To confirm this, qualitative and semi-quantitative ultrastructural evidence on the level of 
fluorescence microscopy, porin-IR was assessed by quantitative immunohistomorphometry. 
Porin is located in the mitochondrial membrane and acts as a channel that enables small 
molecule diffusion and it is often used as a marker for mitochondrial mass (Feichtinger et al., 
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2011). Indeed, 24 hrs of treatment with T3 and TRH significantly increased ORS porin-IR in 
situ, whether T4 and TSH shown just a trend (Figure 3g-l). Thus, all tested HPA-axis 
elements stimulate mitochondrial biogenesis within the epithelium of healthy human HFs. 
 
Thyroid hormones enhance gene expression of HSP60, BMAL and PGC1α in HFs 
Next, we checked the transcription of three additional key players in mitochondrial biology: 
HSP60 (Figure 4a), which protects mitochondria from stress damage (Cappello et al., 2008), 
BMAL1 (Figure 4b), a component of the biological clock with a central role in cell aging 
(Jung-Hynes et al., 2010), and PGC-1α (Figure 4c), the “master regulator of 
mitochondriogenesis” (Safdar et al., 2011). Treatment with T4 (100 nM, 24 hrs) significantly 
increased the mRNA steady-state levels of PGC-1α and HSP90, while T3 (100 pM) 
stimulated HSP60 and BMAL transcription. This underscores that THs potently stimulate 
mitochondrial function in human HFs in situ. 
 
Mitochondrial activity is enhanced by treatment with HPT-axis hormones 
We then asked whether mitochondrial activity itself is also enhanced by THs, using follicular 
heat production as a physical indicator of enhanced mitochondrial energy metabolism. In 
contrast to glycolysis and glutaminolysis, intramitochondrial redox processes strongly 
contribute to the overall heat production (Gnaiger et al., 1990; Jastroch et al., 2010). 
Therefore, changes in the measured heat rate indicate an increase or decrease of the 
electron transfer rate in the electron transport chain (Gnaiger et al., 1990). 
Using chip-calorimetry (Lerchner et al., 2008a, b), we present here the first heat 
measurement of an intact human (mini-)organ in vitro: As shown in Fig. 5, HF treatment with 
T3 (100 pM) resulted in a significantly enhanced heat release compared to vehicle controls. 
Interestingly, HF heat production already increased after only 2 hrs of T3 stimulation.  Figure 
5b shows two examples of the heat rate development of sets of five HFs each are depicted. 
After stabilization of the metabolism, a rather constant signal of about 9 µV could be 
observed over several hours. The corresponding heat rate of about 0.3 µW per follicle is in 
line with previously reported data for metabolic flows of human HFs (Kealy et al., 1994).  
The scarcity of human HFs for study excluded the calorimetric examination of heat 
production effects by T4, TRH or TSH. Instead, we performed classical biochemical enzyme 
activity measurements of key components of the respiratory chain. These showed that T3, T4, 
TRH and TSH all stimulate the activity of both complex I and IV after 24 hrs of treatment 
(Figure 5c-d). Together, these calorimetric and enzymatic activity data demonstrate that the 
tested HPT-axis players not only stimulate mitochondrial gene expression and biogenesis, 
but also mitochondrial activity within normal human scalp HFs. 
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TRH, TSH and TH treatment does not alter the redox state of ORS keratinocytes 
As increased mitochondrial activity can lead to enhanced ROS production and consequently 
to increased oxidation and ROS-mediated cell damage (Gemma et al., 2007; Vendelbo et al., 
2011; Wallace, 2010), enhancing mitochondrial function is not necessarily a beneficial event. 
Therefore, we checked ROS production in cultured ORS keratinocytes, using the ROS-
sensitive CM-H2DCFDA probe (Eruslanov and Kusmartsev, 2010). This showed that, after 24 
hrs of treatment, ROS production did not significantly differ in HF keratinocytes treated with 
any of the HPT-axis hormones compared to vehicle. Rather, T3 and T4 seemed to exert a 
slightly (yet not significant) ROS-protective effect after a 10 minutes H2O2 challenge: while 
there was a moderately increased ROS production in vehicle-, TRH- and TSH-treated cells, 
this was lacking in the TH-treated HF keratinocytes (Figure 6a). 
 
HPT-axis hormones up-regulate the expression of ROS scavenging enzymes by 
human HF keratinocytes 
 Finally, we investigated the transcription of two crucial ROS scavenging enzymes of human 
skin in cultured human ORS keratinocytes, catalase and SOD2 (Chelikani et al., 2004; 
Halliwell and Gutteridge, 2007; Marionnet et al., 2011; Silva et al., 2005; Vafaee et al., 2010) 
which are expressed in human HFs and whose activity likely impacts on HF aging and 
greying (Slominski et al., 2005; Wood et al., 2009). Interestingly, catalase transcription was 
significantly upregulated in all test groups treated with HPT-axis hormones, and TSH and T4 
also enhanced SOD2 mRNA steady-state levels in ORS keratinocytes (Figure 6b and c). 
These cell culture data raise the possibility that HPT-axis players may even boost 
intrafollicular ROS scavenging systems.  
 
 
DISCUSSION 
Taken together, the biochemical, gene expression, ultrastructural, calorimetric and 
quantitative immunohistomorphometric data presented here provide unequivocal evidence 
that the tested HPT-axis hormones rapidly stimulate mitochondrial gene expression and even 
mitochondrial biogenesis within normal human scalp HFs. Moreover, TRH, TSH and THs 
also stimulate mitochondrial activity. These findings are well in line with the long-recognized 
stimulatory role of THs on mitochondrial biology and with the recent discovery of TRH and 
TSH as potent, novel neuroendocrine regulators of human epidermal mitochondrial 
biogenesis and function in situ (Poeggeler et al., 2010a; Knuever et al., 2012).  
Given that more mitochondria or an increased mitochondrial protein expression does not 
necessarily imply increased mitochondrial energy production, it was important to investigate 
the functionality of mitochondrial energy metabolism. This was done by chip-calorimetry and 
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 7 
classical enzyme activity assays. These clearly demonstrate that T3 enhances HF heat 
production and that TRH, TSH and THs stimulate mitochondrial chain complex I and IV 
activity in human HFs. This shows that our relatd prior findings in epidermis and brain tissue 
(Poeggeler et al., 2010a, b; Knuever et al., 2012) also apply to human HFs.  
The current study represents the first systematic characterization of HF mitochondrial biology 
in any mammalian species, and encourages one to further explore the as yet under-
investigated energy metabolism of human HFs (Kealey et al., 1994; Williams et al., 1993). 
They also underscore that, contrary to conventional wisdom in mainstream mitochondrial 
research, not only human epidermis (Birch-Machin et al., 2006; Knuever et al., 2012; 
Poeggeler et al., 2010a), but also the metabolically highly active HFs of human skin offer 
excellent model systems for dissecting the activities, biogenesis, and controls of human 
mitochondria  in situ. Human HF chip-calorimetry even permits one to directly measure heat 
production of a living human (mini-)organ in vitro. Moreover, our data render it likely that, 
besides THs, the intrafollicularly produced HPT axis neurohormones TSH and TRH play a 
role in regulating HF energy metabolism. 
Our findings emphasize the importance of neuroendocrine controls not only in general 
mitochondrial biology (Poeggeler et al., 2010 a,b; Knuever et al., 2012), but also in human 
skin and HF biology (Arck et al., 2006; Slominski et al., 2002, 2007; Paus, 2010, 2011; 
Zmijewski and Slominski, 2011; Slominski and Wortsman, 2000). The corresponding lessons 
learned from studying organ-cultured human HFs, i.e. complex mini-organs, may well be 
transferrable to other less accessible human tissues. The current data also provide clinically 
relevant pointers to how HF aging and HF disease related to declining mitochondrial function 
might be effectively counteracted in the future by endogenous neurohormones produced in 
the human HF itself, i.e. TRH (Gáspár et al., 2010) and TSH (Bodo et al., 2009). This also 
applies to T3 and T4, which have long been known to modulate human HF growth, hair shaft 
quality, and/or pigmentation (Messenger, 2000; van Beek et al., 2008). Both TRH and T4 are 
administered routinely in thyroid medicine and are FDA-approved agents with a well-known 
toxicity profile. Therefore, regulatory hurdles to repositioning these hormones for novel 
“mitochondrial hair medicine” approaches are relatively low. 
Current “mitochondrial medicine” concepts (e.g., Wallace et al., 2010; Wallace, 2011) 
operate under the assumption that, in systems with declining mitochondrial function, the 
therapeutic increase of mitochondrial activity generally has beneficial effects. However, 
increased mitochondrial activity could also have undesirable effects, such as increased ROS 
production (Gemma et al., 2007; Vendelbo et al., 2011). While we could not analyze this in 
human HFs in situ due to insufficient HF availability, our HF keratinocyte data (employed as 
surrogate system) suggest that HPT-axis hormones stimulate HF mitochondrial biogenesis 
and activity without increasing ROS production. These hormones may even promote 
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intrafollicular ROS scavenging by upregulating catalase and SOD2 transcription. Of course, 
only long-term stimulation experiments and in-depth analyses of ROS production, ROS 
scavenging and ROS damage indicators, can dissipate remaining concerns that long-term 
administration of HPT-axis hormones might eventually tip the balance of desired towards 
deleterious effects that could arise from chronically increased intrafollicular mitochondrial 
energy metabolism. Insights won from such long-term human HF studies are likely to provide 
important pointers to future application of HPT-axis hormones in general “mitochondrial 
medicine” and gerontobiology. 
In summary, mitochondrial functions, energy metabolism, and biogenesis of human HFs are 
subject to profound (neuro-)endocrine regulation by TRH, TSH and THs. This underscores 
the importance of further exploring the HPT-axis equivalent system of human skin and its 
appendages, and of dissecting how this system can be therapeutically targeted. 
 
 
MATERIALS AND METHODS 
 
Skin samples, human HF organ culture and ORS keratinocytes culture 
Human scalp skin samples were obtained after written informed consent and institutional 
research board ethics license (University of Luebeck) from 8 healthy middle-aged females 
undergoing routine cosmetic plastic surgery, adhering to Helsinki guidelines and with 
informed patient consent. The varying numbers of HFs and subjects are stated separately in 
each figure legend.  
HF organ culture was performed in serum-free Williams´ E medium supplemented with 
glutamine, insulin, hydrocortisone and an antibiotic/antimycotic mixture as described before 
(Philpott et al., 1990; Bodó et al., 2009; Kloepper et al., 2010; Gáspár et al., 2011). After pre-
culture of microdissected HFs for 24 hrs to minimize dissection-associated disturbances of 
mitochondrial function during this calibration period, vehicle (WE medium only), T3, T4, TRH 
or TSH (Sigma-Aldrich) were added for an additional 24 hrs. After treatment the HF samples 
were shock frozen in liquid nitrogen and stored at -80°C. 6 µm thick sections were cut and 
used for immunostainings. Since only a very limited number of human HFs was available for 
study, one carefully selected concentration was assessed for each hormone, based on prior 
published results:  T3 (100 pM), T4 (100 nM) (van Beek et al., 2008), TRH (30 nM) (Gaspar et 
al., 2010, 2011), TSH (10mU/mL) (Bodó et al., 2009; Poeggeler et al., 2010). 
Human ORS keratinocyte cultures were obtained from face-lift surgery samples of healthy 
subjects. Primary cultures of ORS keratinocytes were established from plucked anagen HFs 
as described (Philpott and Kealey, 1994). Humans ORS keratinocytes (passage 3) were 
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seeded into 96-well plates. After reaching 70% confluency cells were treated with bioactives 
for 24 hrs.  
 
Immunohistochemistry, immunofluoresescence, and quantitative 
immunohistomorphometry 
MTCO1 immunoreactivity (IR) was determined as previously described (Poeggeler et al., 
2010; Knuever et al., 2012). TFAM- and porin-IR were investigated by fluorescence 
microscopy. For staining of the mitochondrial DNA-binding transcription factor TFAM, a rabbit 
polyclonal antiserum (kindly provided by Rudolf Wiesner, University of Cologne, Germany) 
was used 1:200, with +4°C over night (O/N) incubation. As secondary antibody we used a 
goat anti-rabbit Rhodamine (Jackson ImmunoResearch), 1:200, incubated for 2 hrs at room 
temperature.  
VDAC1/Porin was used to depict mitochondrial biogenesis (Feichtinger et al., 2011), utilizing 
a rabbit polyclonal antibody (1:600, O/N at +4°C). As secondary antibody we used a 1:200 
goat anti-rabbit biotinylated antibody (Jackson Immuno Research), incubated for 45 minutes 
at RT. The TSA method was used for detection (Perkin Elmer TSA kit, FITC). Omission of 
the primary antibody served as negative control. Cell nuclei were demarcated by DAPI and 
images were obtained by digital microscope (Keyence, Germany). 
Quantitative immunohistomorphometry was performed by assessing the relative intensity of 
immunoreactivity in precisely defined and standardized HF reference areas with ImageJ 
(NIH), as indicated in the corresponding illustrations. 
 
Transmission electron microscopy (TEM) 
TEM was performed as previously described (Kramer et al., 2005; Knuever et al., 2012). 
Briefly, following a fixation with 2.5% glutaraldehyde for 2 hrs, human dissected HFs were 
washed in 0.1 M cacodylate buffer, pH 7.2. Using 1% osmiumtetroxide samples were 
postfixated, dehydrated in ethanol and embedded in araldite (Fluka, Buchs, Switzerland). 
Ultrathin sections were stained with uranyl acetate and lead citrate and then viewed with a 
Philips electron microscope 400 at 6000x magnification.  
 
Chip calorimetry 
Heat measurements as a reliable indicator of follicular mitochondrial heat production and 
thus activity/energy metabolism were performed using a newly developed prototype chip 
calorimeter (Lerchner et al., 2008a, b) 
The main component of heat measurement by chip calorimetry is a silicon chip with an 
integrated thin film thermopile which consists of 472 BiSb/Sb thermocouples that convert the 
heat rate, produced by the sample located inside the flow channel, into a voltage signal . The 
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complete chip module is enclosed in a high precision thermostat. The fluidic system used for 
the injection of medium consists of two units comprising a stepping motor driven piston pump 
(280 µL) and several micro-valves each (Lerchner et al., 2008a, b). Five dissected HFs were 
inserted into the flow channel and fixed in one segment (Figure 5a). After mounting of the 
flow channel atop the thermopile chip inside the calorimeter and sufficient thermal 
equilibration, the generation of heat signals is stimulated by periodic injections of 280 µL WE 
medium at a flow rate of 50 µLmin-1. After relaxation of an endothermal injection effect 
caused by incomplete thermal equilibration of the injected liquid, an exothermal signal shift 
∆u indicates metabolic heat production by the HFs. The baseline is recovered after about 30 
minutes because of oxygen depletion. After about two hours of periodic injection of WE 
medium the injection was switched to WE medium containing 100 pM T3, delivered by a 
second fluid unit. 
 
Quantitative real-time PCR (qRT-PCR) 
Steady-state mRNA levels from organ-cultured human HFs were studied by qRT-PCR after 
24 hrs of incubation with the HPT-axis hormones for the following key genes of mitochondrial 
biogenesis and/or energy metabolism: MTCO1, TFAM, heat shock protein 60 (HSP60), 
peroxisome proliferator-activated receptor gamma coactivator-1alpha (PGC-1α) and brain 
and muscle ARNT (aryl hydrocarbon receptor nuclear translocator)-like protein 1 (BMAL1) 
(Cappello et al., 2008; Safdar et al., 2011; Jung-Hynes et al., 2010). Gene expression was 
assessed by quantitative real-time PCR performed on an ABI PRISM 7000 Sequence 
Detection System (Applied Biosystems) following the published protocol, and normalized to 
one of three tested housekeeping genes that proved to be least-regulated by the test 
hormone (Knuever et al., 2012).  
The qRT-PCR in ORS keratinocytes for SOD2 and catalase was performed as previously 
described in Giesen et al 2011 (further details, see figure legend). 
 
Biochemical assays 
Complex I and complex IV activity were analyzed in HF homogenates as described by 
Poeggeler et al. (2010), following the protocols of Mazzio et al. (2004), Dabbeni-Sala et al. 
(2001) and Rustin et al. (1994), respectively. Both experiments were performed with 8 HFs 
each and were repeated multiple times, i.e. with HFs from 6 different subjects.  
 
ROS production in ORS keratinocytes  
Production of reactive oxygen species (ROS) was detected using the specific dye CM-
H2DCFDA (Life Technologies), which is oxidized to green fluorescent DCF 
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(dichlorofluorescein) in the presence of ROS according to the manufacturer protocol and as 
indicated in the corresponding figure legend. 
 
Statistical analysis 
If not stated otherwise, all data were analyzed using ANOVA one way analysis of variance 
(Tukey’s test) by employing the Graph Pad Prism software (Graph Pad Prism, USA). 
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Figure 1. MTCO1 expression. HFs were treated with (a) vehicle, (b) T3 (100 pM), (c) T4 
(100 nM), (d) TSH (10 mU/mL) or (e) TRH (30 nM) for 24 hrs and immunostained for MTCO1 
(nuclear counterstain: haematoxylin). DP = dermal papilla, HM = hair matrix, ORS = outer 
root sheath. Magnification: 200x. Quantitative immunohistomorphometry in defined reference 
areas was performed by ImageJ software (NIH). (f) IMTCO1 immunoreactivity compared to 
vehicle. Treatment groups were normalized to the vehicle arbitrarily set at 100. n = 6-11 HFs 
(2 subjects). (g) MTCO1 mRNA steady-state levels (qRT-PCR) in HFs treated with T3 (100 
pM) or T4 (100 nM) for 24 hrs. Data from 15 HFs (1 subject).  
Mean ± SEM (one-way ANOVA), *p < 0.05, **p < 0.01, ***p<0.001.  
 
Figure 2. TFAM expression. HFs treated with (a) vehicle, (b) T3 (100 pM), (c) T4 (100 nM),    
(d) TSH (10 mU/mL) or (e) TRH (30nM) for 24 hrs and immunostained for TFAM (nuclear 
counterstain: DAPI) and evaluated by quantitative immunohistomorphometry. DP = dermal 
papilla, HM = hair matrix, ORS = outer root sheath. Magnification: 200x. (f) Increased 
immunoreactivity compared to vehicle (arbitrarily set to 100). n = 5-10 HFs (2 subjects). (g) 
TFAM mRNA mRNA steady-state levels (qRT-PCR) in HFs treated with T3 (100 pM) or T4 
(100 nM) for 24 hrs. n = 15 HFs (1 subject). 
Mean ± SEM (One-way Anova), **p < 0.01, ***p < 0.001.  
 
Figure 3. Mitochondrial biogenesis. HFs treated with (a, g) vehicle, (b, h) T3 (100 pM), (c, 
h) T4 (100 nM), (d, j) TSH (10 mU/mL) or (e, k) TRH (30nM) for 24 hrs. (a-f) Number of 
ultrastructurally detectable mitochondria (TEM), particularly in the perinuclear region of 
human ORS keratinocytes. n = 10-12 keratinocytes (6 subjects). N=nucleus, red arrows 
indicate exemplary mitochondria. Magnification: 6000x. (g-k) Porin-IR DP = dermal papilla, 
HM = hair matrix, ORS = outer root sheath. Magnification: 200x. (l) Quantitative 
immunohistomorphometry of Porin-IR was assessed by quantitative 
immunohistomorphometry . Data are reported in percentages, normalized to the vehicle. n = 
5-10 HFs (2 subjects). 
Mean ± SEM (one-way ANOVA), * p<0.05, *** p < 0.001.  
 
Figure 4. Mitochondrial gene expression: qRT-PCR. Graphs show mRNA steady-state 
levels for (a) PGC1α, (b) BMAL1 and (c) HSP60 in human HFs treated with T3 (100 pM) or T4 
(100 nM) for 24 hrs. 
Mean ± SEM (One-way Anova), *** p < 0,001, ** p < 0,01. n=15 HFs (1 subject).  
 
Figure 5. HF heat production: Calorimetry. (a) Representation of the calorimetric chip, the 
flow channel and the position of the HFs. (b) Difference of heat production quantified in µV. n 
B C 
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= 8 HFs (2 subjects). The arrow indicate start of the treatment with T3 (100 pM) in the green 
line (■) and red line (▼). The grey line (•) represent subject 2 without treatment. (c, d) 
Human dissected HFs treated with T3 (100pM), T4 (100 nM), TRH (30 nM) or (TSH 10 
mU/mL) for 24 hrs. The graphs show (c) complex I activity (NBT reduction) (n = 6 subjects, 8 
HFs/subjects, mean ± SEM, p<0.001) and (d) complex IV activity in human HF mitochondria 
(n = 6 subjects, 8 HFs/subject, mean ± SEM, p<0.001). 
 
Figure 6. ORS keratinocytes (a-c) treated with T3 (100 pM), T4 (100 nM), TRH (30 nM) or 
TSH (10 mU/mL) for 24 hrs. (a) after incubation with the substances, the medium was 
replaced by 100 µl/well culture medium containing DCFDA and incubated for 30 min. To 
further stimulate oxidative stress in the cell cultures, cells were treated with 30 µM H2O2 for 
30 min. at 37°C. Subsequently, cells were incubated for further 90 min in fresh media and 
fluorescence was measured using a 96-well plate reader (Tecan) with excitation/emission 
wavelengths of 485/527. Graph shows the relative fluorescence unit (RFU) detected by DCF 
measurement reported in percentages where the vehicle (basal level) is set at 100%. Mean ± 
SEM (one-way ANOVA). * p < 0.05, ***p < 0.001, n= 6-24 wells.  
(c,d) qRT-PCR mRNA extracts were analyzed for catalase (NM_001752) and SOD2 
(NM_000636), steady-state levels. After total RNA isolation according to the manufacturer’s 
instructions using the RNeasy MinElute Spin Column system (Qiagen), qRT-PCR was 
performed using a MX3000Pro RT-PCR System (Stratagene). Expression of each gene was 
first normalized against human reference total RNA (Stratagene), which worked as an 
internal standard, and subsequently against the expression of the house keeping gene 
GAPDH.  Mean ± SEM (One-way Anova), * p < 0.05 ** p < 0.01, n = 3 wells.  
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